Relay Therapeutics RLAY
NASDAQ RLAY
$18.02 -0.34 (-1.87%)
As of: Sep 30, 2026 · 1:05 PM EDT

Relay Therapeutics, Inc. (RLAY) Revenue (2021 - 2026)

Updated

Relay Therapeutics (RLAY) reported Revenue of $350,000 for Q2 2026, down 48.3% from $677,000 a year earlier and down 88.3% from the prior quarter.

Analysis

Relay Therapeutics, Inc. (RLAY) Revenue (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Relay Therapeutics' Revenue came in at $10.35 million, up 23.9% year-over-year; for FY2025, it came in at $15.36 million, up 53.4% from FY2024.

  • Revenue has a five-year compound annual growth rate of -28.6% (FY2020 to FY2025).
  • By year, Revenue came in at $10.01 million in FY2024 (-60.8%), $25.55 million in FY2023, $1.38 million in FY2022 (-54.4%) and $3.03 million in FY2021 (-96.3%).
  • The Q2 2026 figure ranks as the lowest quarterly Revenue since Q4 2023.
  • Across the past five years, year-over-year decline in Revenue ran from 23.3% in Q1 2025 to 67.4% in Q2 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 350,000.00
Mar 31, 2026 3.00 Mn
Dec 31, 2025 7.00 Mn
Jun 30, 2025 677,000.00
Mar 31, 2025 7.68 Mn
Mar 31, 2024 10.01 Mn
Dec 31, 2023 -1,000.00
Sep 30, 2023 25.20 Mn
Jun 30, 2023 119,000.00
Mar 31, 2023 226,000.00
Dec 31, 2022 253,000.00
Sep 30, 2022 344,000.00
Jun 30, 2022 365,000.00
Mar 31, 2022 419,000.00
Dec 31, 2021 567,000.00
Sep 30, 2021 666,000.00
Jun 30, 2021 844,000.00
Mar 31, 2021 952,000.00
API Access

Relay Therapeutics, Inc. Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RLAY&period=max&api_key=YOUR_API_KEY